The targeting of WNT5B and WNT10B in osteosarcoma
A new review was published in Oncotarget on August 2, 2024, entitled, "Targeting WNT5B and WNT10B in osteosarcoma."
Sep 4, 2024
0
33
MeSH tree: C04.557.450.565.575
A new review was published in Oncotarget on August 2, 2024, entitled, "Targeting WNT5B and WNT10B in osteosarcoma."
Sep 4, 2024
0
33
Despite decades of advancement in treatment, cancer spreading to multiple parts of the body remains one of the biggest challenges facing patients and their health-care teams.
Sep 4, 2024
0
31
Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient's immune cells to target cancer cells. While successful in some types of leukemia, the approach has yet to realize its potential against pediatric ...
Aug 5, 2024
0
42
A new type of immunotherapy, developed by UCL researchers, has shown promising preclinical results against a bone cancer called osteosarcoma, as part of a study in mice.
May 29, 2024
0
60
ChatGPT, the artificial intelligence (AI) chatbot designed to assist with language-based tasks, can effectively extract data for research purposes from physicians' clinical notes, UT Southwestern Medical Center researchers ...
May 13, 2024
0
74
Researchers at Kyushu University have developed and validated a machine-learning model that can accurately evaluate the density of surviving tumor cells after treatment in pathological images of osteosarcoma—the most prevalent ...
Apr 2, 2024
0
56
A new research paper titled "Roles of USP1 in Ewing sarcoma" has been published in Genes & Cancer.
Feb 14, 2024
0
37
In a study published in the journal Genes & Diseases, scientists from Union Hospital, Tongji Medical College, and Huazhong University of Science and Technology delve into the molecular intricacies of osteosarcoma in the elderly. ...
Dec 4, 2023
0
27
The strangely named hedgehog pathway that's crucial to bone growth has emerged as a key in the fight to treat the bone cancer osteosarcoma.
Nov 28, 2023
0
38
A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN)—or, what percentage of a tumor is "dead" and no longer active—in patients with osteosarcoma, a ...
Nov 2, 2023
0
43